Results 231 to 240 of about 9,287,329 (300)

The cholesterol, high‐density lipoprotein, and glucose index and its derivatives related to obesity and inflammation as novel metabolic markers for predicting new‐onset cardiovascular‐liver‐metabolic multimorbidity: A prospective cohort study

open access: yesJournal of Diabetes Investigation, EarlyView.
The CHG index and its obesity‐derived variants were associated with incident CLMM, with CHG‐BMI showing the strongest association and predictive performance. CHG‐BMI may serve as a simple and accessible metabolic marker for CLMM risk stratification. ABSTRACT Background Cardiovascular‐liver‐metabolic multimorbidity (CLMM), defined as the co‐occurrence ...
Zhonghua Sun   +7 more
wiley   +1 more source

Diabetes attenuates weight reduction‐mediated liver fibrosis regression in persons with morbid obesity

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims Weight loss by laparoscopic sleeve gastrectomy (LSG) compared to medical weight loss (low‐calorie diet: LCD) ameliorates diabetes and metabolic dysfunction‐associated steatotic liver disease (MASLD). We aimed to evaluate changes in liver pathology 1‐year after LSG and their associations with metabolic factors in Japanese participants with
Daiki Matsubara   +11 more
wiley   +1 more source

Clinico-radiological differences between porto-sinusoidal vascular disorder and cirrhosis. [PDF]

open access: yesJHEP Rep
Heo S   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy